Nitz, U., Gluz, O., Christgen, M., Kates, R. E., Clemens, M., Malter, W., . . . Harbeck, N. (2019). Correction to: Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial. Breast Cancer Res Treat.
Chicago Style CitationNitz, Ulrike, et al. "Correction To: Reducing Chemotherapy Use in Clinically High-risk, Genomically Low-risk PN0 and PN1 Early Breast Cancer Patients: Five-year Data From the Prospective, Randomised Phase 3 West German Study Group (WSG) PlanB Trial." Breast Cancer Res Treat 2019.
MLA CitationNitz, Ulrike, et al. "Correction To: Reducing Chemotherapy Use in Clinically High-risk, Genomically Low-risk PN0 and PN1 Early Breast Cancer Patients: Five-year Data From the Prospective, Randomised Phase 3 West German Study Group (WSG) PlanB Trial." Breast Cancer Res Treat 2019.